[1]
|
Kirchhof, P., Benussi, S., Kotecha, D., et al. (2016) 2016 ESC Guidelines for the Management of Atrial Fibrillation De-veloped in Collaboration with EACTS. The European Journal of Cardio-Thoracic Surgery, 50, e1-e88.
|
[2]
|
Owan, T.E., Hodge, D.O., Herges, R.M., Jacobsen, S.J., Roger, V.L. and Redfield, M.M. (2006) Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. The New England Journal of Medicine, 355, 251-259.
https://doi.org/10.1056/NEJMoa052256
|
[3]
|
Steinberg, B.A., Zhao, X., Heidenreich, P.A., et al. (2012) Trends in Patients Hospitalized with Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies and Outcomes. Circulation, 126, 65-75.
https://doi.org/10.1161/CIRCULATIONAHA.111.080770
|
[4]
|
Staerk, L., Sherer, J.A., Ko, D., Benjamin, E.J. and Helm, R.H. (2017) Atrial Fibrillation: Epidemiology, Pathophysiology and Clinical Outcomes. Circulation Research, 120, 1501-1517.
https://doi.org/10.1161/CIRCRESAHA.117.309732
|
[5]
|
Santhanakrishnan, R., Wang, N., Larson, M.G., et al. (2016) Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation, 133, 484-492.
https://doi.org/10.1161/CIRCULATIONAHA.115.018614
|
[6]
|
Goyal, P., Almarzooq, Z.I., Cheung, J., Kamel, H., Krishnan, U., Feldman, D.N., Horn, E.M. and Kim, L.K. (2018) Atrial Fibrillation and Heart Failure with Preserved ejec-tion Fraction: Insights on a Unique Clinical Phenotype from a Nationally-Representative United States Cohort. Interna-tional Journal of Cardiology, 266, 112-118.
https://doi.org/10.1016/j.ijcard.2018.02.007
|
[7]
|
Kotecha, D., Lam, C.S.P., Van Veldhuisen, D.J., Van Gelder, I.C., Voors, A.A. and Rienstra M. (2016) Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins. Journal of the American College of Cardiology, 68, 2217-2228. https://doi.org/10.1016/j.jacc.2016.08.048
|
[8]
|
Effat, M., Schick, E.C., Martin, D.T. and Gaasch, W.H. (2000) Ef-fect of Rhythm Regularization on Left Ventricular Contractility in Patients with Atrial Fibrillation. The American Journal of Cardiology, 85, 114-116.
https://doi.org/10.1016/S0002-9149(99)00620-7
|
[9]
|
Shelton, R.J., Clark, A.L., Goode, K., et al. (2009) A Ran-domised, Controlled Study of Rate versus Rhythm Control in Patients with Chronic Atrial Fibrillation and Heart Failure: (CAFÉ-II Study). Heart, 95, 924-930.
https://doi.org/10.1136/hrt.2008.158931
|
[10]
|
Suman-Horduna, I., Roy, D., Frasure-Smith, N., et al. (2013) Quality of Life and Functional Capacity in Patients with Atrial Fibrillation and Congestive Heart Failure. Journal of the American College of Cardiology, 61, 455-460.
https://doi.org/10.1016/j.jacc.2012.10.031
|
[11]
|
Roy, D., Talajic, M., Nattel, S., et al. (2008) Rhythm Control Ver-sus Rate Control for Atrial Fibrillation and Heart Failure. The New England Journal of Medicine, 358, 2667-2677. https://doi.org/10.1056/NEJMoa0708789
|
[12]
|
Hindricks, G., Potpara, T., Dagres, N., et al. (2021) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Asso-ciation for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42, 373-498. https://doi.org/10.1093/eurheartj/ehaa612
|
[13]
|
Hunter, R.J., Berriman, T.J., Diab, I., et al. (2014) A Randomized Controlled Trial of Catheter Ablation versus Medical Treatment of Atrial Fibrillation in Heart Failure (the CAMTAF Tri-al). Circulation: Arrhythmia and Electrophysiology, 7, 31-38. https://doi.org/10.1161/CIRCEP.113.000806
|
[14]
|
Di Biase, L., Mohanty, P., Mohanty, S., et al. (2016) Ablation versus Amiodarone for Treatment of Persistent Atrial Fibril-lation in Patients with Congestive Heart Failure and an Implanted Device: Results from the AATAC Multicenter Ran-domized Trial. Circulation, 133, 1637-1644. https://doi.org/10.1161/CIRCULATIONAHA.115.019406
|
[15]
|
Marrouche, N.F., Brachmann, J., Andresen, D., et al. (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. The New England Journal of Medicine, 378, 417-427. https://doi.org/10.1056/NEJMoa1707855
|
[16]
|
Zafrir, B., Lund, L.H., Laroche, C., et al. (2018) Prognos-tic Implications of Atrial Fibrillation in Heart Failure with Reduced, Mid-Range and Preserved Ejection fraction: A Report from 14964 Patients in the European Society of Cardiology Heart Failure Long-Term Registry. European Heart Journal, 39, 4277-4284.
https://doi.org/10.1093/eurheartj/ehy626
|
[17]
|
Machino-Ohtsuka, T., Seo, Y., Ishizu, T., et al. (2013) Efficacy, Safety and Outcomes of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology, 62, 1857-1865. https://doi.org/10.1016/j.jacc.2013.07.020
|
[18]
|
Rattka, M., Pott, A., Kühberger, A., et al. (2020) Restoration of Si-nus Rhythm by Pulmonary Vein Isolation Improves Heart Failure with Preserved Ejection Fraction in Atrial Fibrillation Patients. EP Europace, 22, 1328-1336.
https://doi.org/10.1093/europace/euaa101
|
[19]
|
Machino-Ohtsuka, T., Seo, Y., Ishizu, T., et al. (2019) Relationships between Maintenance of Sinus Rhythm and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation. Journal of Cardiology, 74, 235-244. https://doi.org/10.1016/j.jjcc.2019.02.014
|
[20]
|
Steinberg, J.S., O’Connell, H., Li, S. and Ziegler, P.D. (2018) Thir-ty-Second Gold Standard Definition of Atrial Fibrillation and Its Relationship with Subsequent Arrhythmia Patterns: Analysis of a Large Prospective Device Database. Circulation: Arrhythmia and Electrophysiology, 11, e006274. https://doi.org/10.1161/CIRCEP.118.006274
|
[21]
|
Dunlay, S.M., Roger, V.L. and Redfield, M.M. (2017) Epidemi-ology of Heart Failure with Preserved Ejection Fraction. Nature Reviews Cardiology, 14, 591-602. https://doi.org/10.1038/nrcardio.2017.65
|
[22]
|
马文韬, 樊晓寒, 张澍. 心房颤动合并心力衰竭的治疗发展方向[J]. 中国循环杂志, 2016, 31(11): 1142-1144.
|
[23]
|
刘蕾, 张煜, 董丽露, 申彬如, 崔妍. 老年心力衰竭合并慢性房颤的药物治疗[J]. 中国老年学杂志, 2015, 35(8): 2293-2296.
|
[24]
|
Morillo, C.A., Verma, A., Connolly, S.J., et al. (2014) Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial. JAMA, 311, 692-699.
https://doi.org/10.1001/jama.2014.467
|
[25]
|
Black-Maier, E., Ren, X., Steinberg, B.A., et al. (2018) Catheter Abla-tion of Atrial Fibrillation in Patients with Heart Failure and Preserved Ejection Fraction. Heart Rhythm, 15, 651-657. https://doi.org/10.1016/j.hrthm.2017.12.001
|
[26]
|
Lam, C.S.P., Rienstra, M., Tay, W.T., et al. (2017) Atrial Fibrilla-tion in Heart Failure with Preserved Ejection Fraction: Association with Exercise Capacity, Left Ventricular Filling Pres-sures, Natriuretic Peptides and Left Atrial Volume. JACC: Heart Failure, 5, 92-98. https://doi.org/10.1016/j.jchf.2016.10.005
|
[27]
|
Zakeri, R., Borlaug, B.A., McNulty, S.E., et al. (2014) Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A Relax Trial Ancillary Study. Circulation: Heart Failure, 7, 123-130.
https://doi.org/10.1161/CIRCHEARTFAILURE.113.000568
|
[28]
|
Cikes, M., Claggett, B., Shah, A.M., et al. (2018) Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction: The Topcat Trial. JACC: Heart Failure, 6, 689-697. https://doi.org/10.1016/j.jchf.2018.05.005
|
[29]
|
Olsson, L.G., Swedberg, K., Ducharme, A., et al. (2006) Atrial Fi-brillation and Risk of Clinical Events in Chronic Heart Failure with and without Left Ventricular Systolic Dysfunction: Results from the Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Journal of the American College of Cardiology, 47, 1997-2004. https://doi.org/10.1016/j.jacc.2006.01.060
|
[30]
|
Linssen, G.C.M., Rienstra, M., Jaarsma, T., Voors, A.A., van Gelder, I.C., Hillege, H.L. and van Veldhuisen, D.J. (2011) Clinical and Prognostic Effects of Atrial Fibrillation in Heart Failure Patients with Reduced and Preserved Left Ventricular Ejection Fraction. European Journal of Heart Failure, 13, 1111-1120.
https://doi.org/10.1093/eurjhf/hfr066
|
[31]
|
Prabhu, S., Taylor, A.J., Costello, B.T., et al. (2017) Catheter Ablation versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study. Journal of the American College of Cardiology, 70, 1949-1961. https://doi.org/10.1016/j.jacc.2017.08.041
|
[32]
|
Cha, Y.M., Wokhlu, A., Asirvatham, S.J., et al. (2011) Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Dias-tolic Dysfunction: A Comparison to Systolic Dysfunction and Normal Ventricular Function. Circulation: Arrhythmia and Electrophysiology, 4, 724-732. https://doi.org/10.1161/CIRCEP.110.960690
|
[33]
|
Kelly, J.P., De Vore, A.D., Wu, J., et al. (2019) Rhythm Control Versus Rate Control in Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Insights from Get with the Guidelines-Heart Failure. Journal of the American Heart Association, 8, e011560. https://doi.org/10.1161/JAHA.118.011560
|
[34]
|
Rattka, M., Kühberger, A., Pott, A., et al. (2021) Cathe-ter Ablation for Atrial Fibrillation in HFpEF Patients—A Propensity-Score-Matched Analysis. Journal of Cardiovascu-lar Electrophysiology, 32, 2357-2367.
https://doi.org/10.1111/jce.15200
|